Quantification of mouse pulmonary cancer models by microcomputed tomography imaging

Cancer Science

Volumn 100, Issue 8, 2009, Pages 1544-1549

  Fushiki, Hiroshi ^a   Kanoh Azuma, Tomoko ^a   Katoh, Masahiro ^a   Kawabata, Ken ^a   Jiang, Jian ^a   Tsuchiya, Nozomi ^a   Satow, Akio ^a   Tamai, Yoshitaka ^a   Hayakawa, Yoshihiro ^a,b  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; K RAS PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESEARCH; HISTOPATHOLOGY; IMAGE ANALYSIS; LUNG CANCER; LUNG CARCINOMA; MALE; MICRO-COMPUTED TOMOGRAPHY; MONITORING; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CISPLATIN; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; GENES, RAS; LENTIVIRUS; LUCIFERASES; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RANDOM ALLOCATION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; X-RAY MICROTOMOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67650648484     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01199.x     Document Type: Article

References (26)

1. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359 (13): 1367-80.
2. Frese KK. Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer 2007; 7 (9): 645-58.
3. Sharpless NE, Depinho RA. The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006; 5 (9): 741-54.
4. Doki Y, Murakami K, Yamaura T, Sugiyama S, Misaki T, Saiki I. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br J Cancer 1999; 79 (7-8): 1121-6.
5. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15 (24): 3243-8.
6. Jackson EL, Olive KP, Tuveson DA, et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 2005; 65 (22): 10280-8.
7. Olive KP. Tuveson DA. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res 2006; 12 (18): 5277-87.
8. Hollingshead MG. Antitumor efficacy testing in rodents. J Natl Cancer Inst 2008; 100 (21): 1500-10.
9. Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA. In vivo imaging in experimental preclinical tumor research -a review. Cytometry A 2007; 71 (8): 542-9.
10. Angelucci A, Gravina GL, Rucci N, et al. Evaluation of metastatic potential in prostate carcinoma: An in vivo model. Int J Oncol 2004; 25 (6): 1713-20.
11. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997; 66 (4): 523-31.
12. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999;1 (4): 303-10.
13. Jenkins DE, Yu SF, Hornig YS, Purchio T, Contag PR. In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 2003; 20 (8): 745-56.
14. Sweeney TJ, Mailander V, Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 1999; 96 (21): 12044-9.
15. Cavanaugh D, Johnson E, Price RE, Kurie J, Travis EL, Cody DD. In vivo respiratory-gated micro-CT imaging in small-animal oncology models. Mol Imaging 2004; 3 (1): 55-62.
16. Cody DD, Nelson CL, Bradley WM, et al. Murine lung tumor measurement using respiratory-gated micro-computed tomography. Invest Radiol 2005; 40 (5): 263-9.
17. De Clerck NM, Meurrens K, Weiler H, et al. High-resolution X-ray microtomography for the detection of lung tumors in living mice. Neoplasia 2004; 6 (4): 374-9.
18. Greschus S, Savai R, Wolf JC, et al. Non-invasive screening of lung nodules in mice comparing a novel volume tric computed tomography with a clinical multislice CT. Oncol Rep 2007; 17 (4): 707-12.
19. Li XF, Zanzonico P, Ling CC, O'Donoghue J. Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography. Technol Cancer Res Treat 2006; 5 (2): 147-55.
20. Paulus MJ, Gleason SS, Kennel SJ, Hunsicker PR, Johnson DK. High resolution X-ray computed tomography: An emerging tool for small animal cancer research. Neoplasia 2000; 2 (1-2): 62-70.
21. Winkelmann CT, Figueroa SD, Rold TL, Volkert WA, Hoffman TJ. Microimaging characterization of a B16-F10 melanoma metastasis mouse model. Mol Imaging 2006; 5 (2): 105-14.
22. Yamaura T, Murakami K, Doki Y, et al. Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer. Neoplasia 2000; 2 (4): 315-24.
23. Hoess RH, Abremski K. Interaction of the bacteriophage P1 recombinase Cre with the recombining site loxP. Proc Natl Acad Sci U S A 1984; 81 (4): 1026-9.
24. Lakso M, Sauer B, Mosinger B Jr, et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A 1992; 89 (14): 6232-6.
25. Ji H, Houghton AM, Mariani TJ, et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006; 25 (14): 2105-12.
26. Wetterwald APG, Que I, Sijmons B, et al. Optical imaging of cancer metastasis to bone marrow: A mouse model of minimal residual disease. Am J Pathol 2002; 160 (3): 1143-53.